A case of medulloblastoma and disseminated basal cell carcinoma of the skin in an 11‑year‑old female patient
Open Access
- 11 November 2025
- journal article
- Published by Alfmed LLC in Medical alphabet
- Vol. 1 (23) , 58-62
Abstract
Gorlin‑Goltz syndrome (GGS) is a rare autosomal dominant disorder caused by mutations in the PTCH1 and SUFU genes, key components of the Sonic Hedgehog signaling pathway. GGS is characterized by a high risk of developing tumors, primarily basal cell carcinoma (BCC) and medulloblastoma. The article presents a clinical case of an 11‑year‑old patient with PTCH1‑associated GGS, who was diagnosed with medulloblastoma at the age of 3 years, and by the age of 6 years, multiple basal cell skin cancer manifested. The clinical case highlights the importance of early diagnosis, timely molecular genetic testing and interdisciplinary monitoring to improve the prognosis and quality of life of patients with this syndrome.Keywords
This publication has 10 references indexed in Scilit:
- Basal cell nevus syndrome: an update on clinical findingsInternational Journal of Dermatology, 2021
- Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG)Familial Cancer, 2021
- Gorlin-Goltz Syndrome: A Case Report and Literature ReviewCureus, 2019
- New mutations and an updated database for the patched‐1 (PTCH1) geneMolecular Genetics & Genomic Medicine, 2018
- Familial Tumor Syndromes2017
- Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosisNeuro-Oncology, 2017
- First evidence of genotype–phenotype correlations in Gorlin syndromeJournal of Medical Genetics, 2017
- Risk Factors for Basal Cell Carcinoma Among Patients With Basal Cell Nevus SyndromeJAMA Dermatology, 2017
- Goltz-Gorlin syndrome: Case report and literature reviewJournal of Oral and Maxillofacial Pathology, 2015
- Basal Cell Carcinomas in Gorlin Syndrome: A Review of 202 PatientsJournal of Skin Cancer, 2011